Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Biofrontera Inc. (NASDAQ: BFRI)
BFRI Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
11%
Analyst Rating:
BUY
Analyst Forecast (1yr):
204.40%
BFRI Stock Analysis
BFRI
PE Ratio:
BFRI
PEG Ratio:
Not Available
BFRI
Forward EPS Growth (12 month):
0.00%
BFRI
PS Ratio:
0.3
BFRI
PSG Ratio:
BFRI
Forward Revenue Growth (12 month):
17.00%
BFRI Articles
No data was found